Table 6. DTG Assay Selectivity in the Presence of Concomitant Medications.
DTG | |
---|---|
| |
Drug Name | Mean % of LQC |
didanosine (ddI) | 103.7 |
stavudine (d4T) | 103.0 |
lamivudine (3TC) | 109.0 |
zalcitibine (ddC) | 102.7 |
zidovudine (AZT) | 101.2 |
abacavir (ABV) | 104.2 |
tenofovir (TFV) | 99.3 |
emtricitabine (FTC) | 100.7 |
nevirapine (NVP | 100.2 |
efavirenz (EFV) | 102.7 |
etravirine (ETV) | 104.0 |
amprenavir (APV) | 97.3 |
indinavir (IDV) | 102.5 |
darunavir (DRV) | 94.5 |
saquinavir (SQV) | 104.7 |
atazanavir (ATV) | 108.2 |
lopinavir (LPV) | 99.0 |
ritonavir (RTV) | 105.0 |
nelfinavir (NFV) | 99.0 |
maraviroc (MVC) | 102.2 |
raltegravir (RAL) | 102.5 |
acyclovir (ACV) | 106.7 |
ganciclovir (GCV) | 101.0 |